1
|
Beltran H, Beer TM, Saad F, Sternberg C
and Tagawa ST: New therapies for castration-resistant prostate
cancer: Efficacy and safety. Eur Urol. 60:279–290. 2011. View Article : Google Scholar : PubMed/NCBI
|
2
|
Martin GS: Cell signaling and cancer.
Cancer Cell. 4:167–174. 2003. View Article : Google Scholar : PubMed/NCBI
|
3
|
Kase S, Sugio K, Yamazaki K, Okamoto T,
Yano T and Sugimachi K: Expression of E-cadherin and beta-catenin
in human non-small cell lung cancer and the clinical significance.
Clin Cancer Res. 6:4789–4796. 2000.
|
4
|
Hay ED: An overview of
epithelio-mesenchymal transformation. Acta Anat (Basel). 154:8–20.
1995. View Article : Google Scholar
|
5
|
Kalluri R and Weinberg RA: The basics of
epithelial-mesenchymal transition. J Clin Invest. 119:1420–1428.
2009. View
Article : Google Scholar : PubMed/NCBI
|
6
|
Cano A, Perez-Moreno MA, Rodrigo I,
Locascio A, Blanco MJ, del Barrio MG, Portillo F and Nieto MA: The
transcription factor snail controls epithelial-mesenchymal
transitions by repressing E-cadherin expression. Nat Cell Biol.
2:76–83. 2000. View
Article : Google Scholar : PubMed/NCBI
|
7
|
Hajra KM, Chen DY and Fearon ER: The SLUG
zinc-finger protein represses E-cadherin in breast cancer. Cancer
Res. 62:1613–1618. 2002.PubMed/NCBI
|
8
|
Smit MA and Peeper DS: Zeb1 is required
for TrkB-induced epithelial-mesenchymal transition, anoikis
resistance and metastasis. Oncogene. 30:3735–3744. 2011. View Article : Google Scholar : PubMed/NCBI
|
9
|
Comijn J, Berx G, Vermassen P, Verschueren
K, van Grunsven L, Bruyneel E, Mareel M, Huylebroeck D and van Roy
F: The two-handed E box binding zinc finger protein SIP1
downregulates E-cadherin and induces invasion. Mol Cell.
7:1267–1278. 2001. View Article : Google Scholar : PubMed/NCBI
|
10
|
Yang J, Mani SA, Donaher JL, Ramaswamy S,
Itzykson RA, Come C, Savagner P, Gitelman I, Richardson A and
Weinberg RA: Twist, a master regulator of morphogenesis, plays an
essential role in tumor metastasis. Cell. 117:927–939. 2004.
View Article : Google Scholar : PubMed/NCBI
|
11
|
Singh S, Sadacharan S, Su S, Belldegrun A,
Persad S and Singh G: Overexpression of vimentin: Role in the
invasive phenotype in an androgen-independent model of prostate
cancer. Cancer Res. 63:2306–2311. 2003.PubMed/NCBI
|
12
|
Zhao Y, Yan Q, Long X, Chen X and Wang Y:
Vimentin affects the mobility and invasiveness of prostate cancer
cells. Cell Biochem Funct. 26:571–577. 2008. View Article : Google Scholar : PubMed/NCBI
|
13
|
Kouzarides T: Chromatin modifications and
their function. Cell. 128:693–705. 2007. View Article : Google Scholar : PubMed/NCBI
|
14
|
Shilatifard A: Chromatin modifications by
methylation and ubiquitination: Implications in the regulation of
gene expression. Ann Rev Biochem. 75:243–269. 2006. View Article : Google Scholar : PubMed/NCBI
|
15
|
Esteller M: Cancer epigenomics: DNA
methylomes and histone-modification maps. Nat Rev Genet. 8:286–298.
2007. View
Article : Google Scholar : PubMed/NCBI
|
16
|
Gronbaek K, Treppendahl M, Asmar F and
Guldberg P: Epigenetic Changes in cancer as potential targets for
prophylaxis and maintenance therapy. Basic Clin Pharmacol Toxicol.
103:389–396. 2008. View Article : Google Scholar : PubMed/NCBI
|
17
|
Couture JF, Collazo E, Brunzelle JS and
Trievel RC: Structural and functional analysis of SET8, a histone
H4 Lys-20 methyltransferase. Genes Dev. 19:1455–1465. 2005.
View Article : Google Scholar : PubMed/NCBI
|
18
|
Fang J, Feng Q, Ketel CS, Wang H, Cao R,
Xia L, Erdjument-Bromage H, Tempst P, Simon JA and Zhang Y:
Purification and functional characterization of SET8, a nucleosomal
histone H4-lysine 20-specific methyltransferase. Curr Biol.
12:1086–1099. 2002. View Article : Google Scholar : PubMed/NCBI
|
19
|
Yang F, Sun L, Li Q, Han X, Lei L, Zhang H
and Shang Y: SET8 promotes epithelial-mesenchymal transition and
confers TWIST dual transcriptional activities. EMBO J. 31:110–123.
2012. View Article : Google Scholar :
|
20
|
Li Z, Nie F, Wang S and Li L: Histone H4
Lys 20 monomethylation by histone methylase SET8 mediates Wnt
target gene activation. Proc Natl Acad Sci USA. 108:3116–3123.
2011. View Article : Google Scholar : PubMed/NCBI
|
21
|
Talasz H, Lindner HH, Sarg B and Helliger
W: Histone H4-lysine 20 monomethylation is increased in promoter
and coding regions of active genes and correlates with
hyperacetylation. J Biol Chem. 280:38814–38822. 2005. View Article : Google Scholar : PubMed/NCBI
|
22
|
Wong TS, Gao W and Chan JY: Transcription
regulation of E-cadherin by zinc finger E-box binding homeobox
proteins in solid tumors. Biomed Res Int. 2014:9215642014.
View Article : Google Scholar : PubMed/NCBI
|
23
|
Park SI, Zhang J, Phillips KA, Araujo JC,
Najjar AM, Volgin AY, Gelovani JG, Kim SJ, Wang Z and Gallick GE:
Targeting SRC family kinases inhibits growth and lymph node
metastases of prostate cancer in an orthotopic nude mouse model.
Cancer Res. 68:3323–3333. 2008. View Article : Google Scholar : PubMed/NCBI
|